Bolt Biotherapeutics, Inc.
BOLT
$5.32
$0.050.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.14M | -8.56M | -11.04M | -15.94M | -15.18M |
| Total Depreciation and Amortization | 290.00K | 347.00K | 399.00K | 426.00K | 440.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 913.00K | 1.08M | 827.00K | 2.28M | 1.35M |
| Change in Net Operating Assets | -3.79M | -2.46M | -3.55M | -1.20M | -578.00K |
| Cash from Operations | -9.73M | -9.60M | -13.37M | -14.43M | -13.97M |
| Capital Expenditure | -72.00K | -- | -- | 0.00 | -41.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 963.00K | 0.00 | 148.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.96M | 10.79M | 13.59M | 12.23M | 17.03M |
| Cash from Investing | 17.88M | 10.79M | 14.55M | 12.23M | 17.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 14.00K | -- | 29.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 14.00K | -- | 29.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.15M | 1.21M | 1.19M | -2.17M | 3.17M |